CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Loading
Home
News
Creighton launches anesthesiology residency programs in Omaha and Phoenix

From Creighton University News

June 2, 2026

Creighton launches anesthesiology residency programs in Omaha and Phoenix

The Creighton University School of Medicine has launched new anesthesiology and perioperative medicine residency programs in Omaha and Phoenix, an initiative designed to help address a growing national shortage of anesthesiologists while preparing future physicians through rigorous clinical training and compassionate patient care. According to the Association of American Medical Colleges, the United States could face a shortage of 10,300 to 35,600 physicians in specialties such as anesthesiology by 2034.

View original article on creighton.edu

Most Recent

Always on, always listening: New AI devices are pushing legal limits and could put users in jeopardy

AI always-listening wearables from Apple, Amazon, Meta and other startups are getting creative with privacy rules and fueling concerns about covert recordings.

Oct 18, 2026

47+ large US data center projects were delayed, withdrawn, or blocked in 2026; Bernstein says ~35% of the planned US data center pipeline is credible

A vast bet on the future of the technology is running into the unforgiving economics of the physical world

Oct 17, 2026

AI debt worries mount as CoreWeave's bond yield tops 15%, insuring SoftBank debt gets pricier, and some Oracle debt trades near 80 to 90 cents on the dollar

Debt trouble at CoreWeave, Oracle and SoftBank raises questions about whether there are broader problems with the data center build-out.

Oct 17, 2026

Exclusive: ‘I’ve seen this movie before’: A Michigan-raised ex-Tesla exec raises $45 million to break China’s grip on batteries

Steven Prast is old enough to remember when a mobile phone came in a bag. It was too heavy to carry around, so most people mounted it in the car.

Oct 17, 2026

Similar Posts

National Academy of Medicine Names Seven NAM Fellows for 2026

The National Academy of Medicine selected seven health professionals for its 2026 class of NAM fellows, spanning fellowship programs in nursing, anesthesiology research, family medicine, osteopathic medicine, pharmacy, and state health policy. The fellows will spend two years working part time with National Academies study committees and roundtables while retaining their academic posts.

Aug 5, 2026

Carver College of Medicine recognized in 2026-2027 ‘Best Graduate Schools’ rankings by ‘US News & World Report’

U.S. News & World Report ranked Carver College of Medicine PA studies No. 1 and physical therapy No. 2 in the 2026-2027 Best Graduate Schools rankings.

Apr 9, 2026

Creighton University announces record 100 million dollar investment from Heider Family Foundation

Creighton University received a record $100 million donation from the Heider Family Foundation, jumpstarting a $300 million campus investment. The gift will fund the Jaywalk, recreational sports facilities, a new residence hall, and the Creighton Quad, along with improvements to nationally recognized athletic programs.

Sep 17, 2025

Campus leaders break ground on the Creighton Quad

Creighton University hosted a groundbreaking ceremony for the Creighton Quad, a 5.7-acre green space that will become the largest physical reshaping of campus in the University's 147-year history. Estimated at $22-25 million and entirely donor-supported, the Quad opens in fall 2026.

Sep 10, 2025